Biochemical Engineering Special Interest Group
biological engineering professionals
12 July 2016

NICE recommends certolizumab pegol in draft guidance

The National Institute for Health and Care Excellence (NICE) has published draft guidance recommending UCB’s Cimzia (certolizumab pegol) for people with severe rheumatoid arthritis. Source: European Pharmaceutical Review 12/7/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).